Fig. 1From: Utility of sustainable ratio derivative spectrophotometry for the concurrent assay of synergistic repurposed drugs for COVID-19 infections; Insilico pharmacokinetics proofChemical structures of (A) Fluvoxamine, and (B) IvermectinBack to article page